Skip to main content
Clinical Trials/NCT02666872
NCT02666872
Completed
N/A

Evaluation of a New Educational Strategy Promoting Vaccination in Maternity in Quebec Based on Motivational Interviewing Techniques: PROMOVAQ Study

Université de Sherbrooke4 sites in 1 country2,719 target enrollmentJune 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Motivational Interviewing
Sponsor
Université de Sherbrooke
Enrollment
2719
Locations
4
Primary Endpoint
Vaccination status of the child at 7 months of age
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Vaccination greatly reduced mortality and morbidity from many preventable diseases. However, to avoid the resurgence of these diseases and the human drama associated, high vaccine coverage should be maintained in the population. Yet in Quebec, vaccine coverage (VC) in young children remains suboptimal, especially caused by a proportion of parents who are ambivalent about the safety and effectiveness of vaccines. In this context, the Provincial Immunization Committee developed in 2010 a Quebec's immunization promotion plan.

Therefore, our research team tested and validated across the Eastern Townships, a vaccination promotion concept by means of an educational intervention within maternities, based on motivational interviewing techniques. This intervention has not only significantly increased the intention of vaccination (+15%) within parents who had received the intervention but also increased their child vaccination coverage (+7.5% at 7 months). This is the purpose of the PROMOVAQ study (PROmotion of VAccination in Quebec) This research project evaluated the impact of an educational strategy based on motivational interviewing techniques within maternity ward on infants' VC. This strategy has been tested through a provincial study (Montreal, Quebec, Sherbrooke) including more than 2500 families.

At term, this research program will offer the Quebec's Health Ministry an optimal strategy for immunization awareness so that Quebec's children may grow healthy and thrive.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
January 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Arnaud Gagneur

MD, Ph.D, Associate Professor

Université de Sherbrooke

Eligibility Criteria

Inclusion Criteria

  • Parents of all infants born in each participating maternity hospitals
  • In Sherbrooke, inclusion limited to parents residing in the region of the Eastern Townships
  • In Québec, inclusion limited to parents residing in the National Capital region.

Exclusion Criteria

  • Minor parents
  • Parents who do not speak English or French
  • Any health condition of the child or the mother needing acute care. That is to say, if the child must be hospitalized in neonatology, or if the mother has an incompatible condition with an interview.

Outcomes

Primary Outcomes

Vaccination status of the child at 7 months of age

Time Frame: 10 months

Data was collected at 10 months of age for all children from regional immunization registries or self-reported by parents over the phone. Vaccination coverage is then defined by the number of infants who received all recommended childhood vaccines at 7 months of age by the total number of children.

Secondary Outcomes

  • Vaccination status of the child at 3 and 5 months of age(10 months)
  • Vaccination status of the child at 13, 19 and 24 months of age(24 months)
  • Hesitancy 's parents to vaccination by a questionnaire based on the Opel's tool to measure vaccine hesitancy(Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention)
  • Intention's parents to vaccination assessed by a questionnaire based on the Health Belief Model(Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention)

Study Sites (4)

Loading locations...

Similar Trials